These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35104459)

  • 1. Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample.
    Taduru SS; Goyal A; Dalia T; Mastoris I; Rali AS; Acharya P; Weidling R; Sauer A; Haglund N; Shah Z
    Indian Heart J; 2022; 74(2):148-150. PubMed ID: 35104459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    Iso T; Maeda D; Matsue Y; Dotare T; Sunayama T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Heart; 2023 Aug; 109(18):1387-1393. PubMed ID: 37185298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sarcoidosis and ventricular arrhythmias. A rare association of a rare disease. A retrospective cohort study from the National Inpatient Sample and current evidence for management.
    Salama A; Abdullah A; Wahab A; Eigbire G; Hoefen R; Alweis R
    Cardiol J; 2020; 27(3):272-277. PubMed ID: 30234899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.
    Kandolin R; Lehtonen J; Kupari M
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):303-9. PubMed ID: 21427276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: Insights from the National Inpatient Sample database (2002-2018).
    Tan JL; Jin C; Lee JZ; Gaughan J; Iwai S; Russo AM
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2585-2598. PubMed ID: 36335632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis.
    Rosenthal DG; Fang CD; Groh CA; Nah G; Vittinghoff E; Dewland TA; Vedantham V; Marcus GM
    J Am Heart Assoc; 2021 Feb; 10(5):e017692. PubMed ID: 33599141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of inflammation due to cardiac sarcoidosis by positron emission tomography-computed tomography imaging and endocardial voltage mapping in a patient with recurrent ventricular tachycardia.
    Siddiqi FK; Paz YE; Olesnicky L; Bokhari S; Cheung JW
    Europace; 2014 Jun; 16(6):907. PubMed ID: 24692516
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in Hospitalizations for Cardiac Sarcoidosis in the United States, 2005-2011.
    Guo X; Vittinghoff E; Vedantham V; Pletcher MJ; Lee BK
    Circ J; 2017 Oct; 81(11):1739-1741. PubMed ID: 28904267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.
    Papageorgiou N; Providência R; Bronis K; Dechering DG; Srinivasan N; Eckardt L; Lambiase PD
    Europace; 2018 Apr; 20(4):682-691. PubMed ID: 28444174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoid myocarditis with ventricular tachycardia mimicking ARVD/C.
    Ladyjanskaia GA; Basso C; Hobbelink MG; Kirkels JH; Lahpor JR; Cramer MJ; Thiene G; Hauer RN; V Oosterhout MF
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):94-8. PubMed ID: 19473301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sarcoidosis: a cause of infiltrative cardiomyopathy.
    Fasano R; Rimmerman CM; Jaber WA
    Cleve Clin J Med; 2004 Jun; 71(6):483-8. PubMed ID: 15242303
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
    Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis: presenting as ventricular tachycardia.
    Molaee P; Teo KS; Wong DT; Leong DP; Sanders P; Worthley SG
    Tex Heart Inst J; 2011; 38(5):602-3. PubMed ID: 22163149
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Yoshitomi R; Kobayashi S; Yano Y; Nakashima Y; Fujii S; Nanno T; Ishiguchi H; Fukuda M; Yoshiga Y; Okamura T; Suga K; Kawano R; Yano M
    Heart; 2022 Mar; 108(6):429-437. PubMed ID: 35078868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
    Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand.
    Chow KL; O'Donnell JL; Crozier I
    Int J Cardiol; 2022 Jun; 357():128-133. PubMed ID: 35395288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis.
    Kaur D; Roukoz H; Shah M; Yalagudri S; Pandurangi U; Chennapragada S; Narasimhan C
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):612-620. PubMed ID: 31916658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
    Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
    Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.